1. Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
    Rahul Shukla et al, 2020, Frontiers in Cellular and Infection Microbiology CrossRef
  2. The effects of Japanese encephalitis virus antibodies on Zika virus infection
    Xiaoen He et al, 2020, Medical Microbiology and Immunology CrossRef
  3. Zika Virus-Immune Plasmas from Symptomatic and Asymptomatic Individuals Enhance Zika Pathogenesis in Adult and Pregnant Mice
    Byoung-Shik Shim et al, 2019, mBio CrossRef
  4. Optimized high-yield expression of envelope glycoprotein domain III from dengue virus serotypes 1 to 4
    Disharee Mallick et al, 2024, Biochimie CrossRef
  5. Diagnostic Performance of Dengue Virus Envelope Domain III in Acute Dengue Infection
    Ngoc Minh Nguyen et al, 2019, International Journal of Molecular Sciences CrossRef
  6. Production of dengue virus-like particles serotype-3 in silkworm larvae and their ability to elicit a humoral immune response in mice
    Doddy Irawan Setyo Utomo et al, 2020, AMB Express CrossRef
  7. Lateral flow immunoassay (LFIA) for dengue diagnosis: Recent progress and prospect
    Ziting Ma et al, 2024, Talanta CrossRef
  8. Plant‐expressed Fc‐fusion protein tetravalent dengue vaccine with inherent adjuvant properties
    Mi Young Kim et al, 2018, Plant Biotechnology Journal CrossRef
  9. Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
    Jyotiranjan Bal et al, 2018, Microbial Cell Factories CrossRef
  10. Serotype‐Specific Dengue Virus IgG Assay Using EDIII‐Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil
    Samuel Santos Pereira et al, 2024, Journal of Medical Virology CrossRef
  11. Laser-cut paper-based device for the detection of dengue non-structural NS1 protein and specific IgM in human samples
    G. Theillet et al, 2018, Archives of Virology CrossRef
  12. [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation
    Yi-hong Wan et al, 2020, Acta Pharmacologica Sinica CrossRef
  13. An Engineered N-Glycosylated Dengue Envelope Protein Domain III Facilitates Epitope-Directed Selection of Potently Neutralizing and Minimally Enhancing Antibodies
    Napon Nilchan et al, 2024, ACS Infectious Diseases CrossRef